Pfizer Inc (NYSE:PFE)

31.12
Data as of Dec 17
 +0.45 / +1.47%
Today’s Change
27.51
Today|||52-Week Range
33.12
+1.60%
Year-to-Date
Jacobs Drives Organic Growth on Award-Winning Contract - Analyst Blog
Dec 17 / Zacks.com
3 Stocks That Might Slash Their Dividends in 2015
Dec 14 / MotleyFool.com
OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog
Dec 17 / Zacks.com
Mylan Among First to Launch Generic Celebrex - Analyst Blog
Dec 11 / Zacks.com
Why The Smart Money is Betting Billions On PetSmart
Dec 17 / MotleyFool.com
Pfizer (PFE) Marked As A Barbarian At The Gate
Dec 11 / TheStreet.com
Juno Therapeutics vies for cancer treatment lead
Dec 17 / FT.com
20 Largest U.S. Companies By Market Capitalization
Dec 11 / TheOnlineInvestor.com
Better Big Pharma Spinoff: Zoetis Inc. or AbbVie Inc.?
Dec 17 / MotleyFool.com
3 Reasons Pfizer, Inc. Could Soar in 2015
Dec 11 / MotleyFool.com
Pfizer, Inc. Invests in Growth... Literally
Dec 17 / MotleyFool.com
Can Pfizerbs Cholesterol Drug Catch Up To The Competition?
Dec 11 / MotleyFool.com
Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics - Analyst Blog
Dec 16 / Zacks.com
Mylan pays bonuses to ease 'spinversion'
Dec 10 / FT.com
OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog
Dec 16 / Zacks.com
6 ugly stocks that look sexy in 2015
Dec 10 / CNNMoney.com
Pfizer Ponies Up to Develop Long-acting Growth Hormone
Dec 16 / TheStreet.com
Fraudsters' robots to cost marketers $6bn
Dec 09 / FT.com
3 Beaten Down Stocks Ready to Bounce Back
Dec 16 / MotleyFool.com
This Could Be the Next Big Pharma Buyout
Dec 08 / MotleyFool.com
3 Reasons GlaxoSmithKline PLC Could Soar in 2015
Dec 16 / MotleyFool.com
Is It Time to Buy This Growth Stock?
Dec 08 / MotleyFool.com
A Shift From Healthcare To Discretionary
Dec 16 / StockTwits
Old drugs put under the microscope
Dec 07 / FT.com
Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog
Dec 15 / Zacks.com
The 3 Most Memorable Moments in Healthcare This Year
Dec 07 / MotleyFool.com
Opko Health Inks Pfizer License Pact
Dec 15 / Benzinga
This Pet Food Supplier Is Still In the Hunt for Growth
Dec 04 / MotleyFool.com
Jim Cramer Says Twitter Needs Better Management for Stock to Rise
Dec 15 / TheStreet.com
'Milestone' in fight against Aids as treatment outpaces infections
Nov 30 / FT.com
Pre-Open Stock Movers 12/15: (TLM) (OPK) (CRUS) Higher; (UPIP) (XCO) (F) Lower (more....
Dec 15 / Investing Channel
S&P 500 bull run defies doubts over valuations
Nov 26 / FT.com
Why Opko Health Inc.'s Shares Got a Shot to the Arm Today
Dec 15 / MotleyFool.com
AstraZeneca comes into focus as Pfizer's cooling-off period ends
Nov 25 / FT.com
Opko Health Soars 13% On Pfizer hGh-CTP News
Dec 15 / Benzinga
AstraZeneca fleshes out standalone strategy
Nov 18 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.